Intrinsic Value of S&P & Nasdaq Contact Us

Lineage Cell Therapeutics, Inc. LCTX NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lineage Cell Therapeutics, Inc. (LCTX) has 12 identified peers for comparison in the Healthcare sector. Peers include ADCT, AGE, ARMP, AUTL, BNTC, BOLT and others.

LCTX has a market capitalization of $406.01M, compared to an average peer market cap of $234.29M. LCTX is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message